The circadian basis of mood disorders: Recent developments and treatment implications

European Neuropsychopharmacology

Volumn 18, Issue 10, 2008, Pages 701-711

  Monteleone, Palmiero ^a   Maj, Mario ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Circadian rhythms; Depression; Endogenous clock; Mood disorders

Indexed keywords

AGOMELATINE; ANTIDEPRESSANT AGENT; MELATONIN; VENLAFAXINE;

CIRCADIAN RHYTHM; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; NEUROBIOLOGY; PATHOGENESIS; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; SEASONAL AFFECTIVE DISORDER; SLEEP DEPRIVATION; SLEEP WAKING CYCLE;

ANIMALS; BIOLOGICAL CLOCKS; CIRCADIAN RHYTHM; HUMANS; MOOD DISORDERS;

EID: 49649102817     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2008.06.007     Document Type: Review

References (121)

1. Abe M., Herzog E.D., and Block G.D. Lithium lengthens the circadian period of individual suprachiasmatic nucleus neurons. NeuroReport 11 (2000) 3261-3264
2. Aǧargün M.Y., Kara H., and Solmaz M. Sleep disturbances and suicidal behavior in patients with major depression. J. Clin. Psychiatry 58 (1997) 249-251
3. Armitage R. The effects of antidepressants on sleep in patients with depression. Can. J. Psychiatry 45 (2000) 803-809
4. Armstrong S.M., McNulty O.M., Guardiola-Lemaitre B., and Redman J.R. Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS). Pharmacol. Biochem. Behav. 46 (1993) 45-49
5. Avery D., Wildschiodtz G., and Rafaelsen O. REM latency and temperature in affective disorder before and after treatment. Biol. Psychiatry 17 (1982) 463-470
6. Avery D.H., Dahl K., Savage M.V., Brengelman G.L., Larsen L.H., Kenny M.A., Eder D.N., Vitiello M.V., and Prinz P.N. Circadian temperature and cortisol rhythms during a constant routine are phase-delayed in hypersomnic winter depression. Biol. Psychiatry 41 (1997) 1109-1123
7. Barden N., Shink E., Labbé M., Vacher R., Rochford J., and Mocaër E. Antidepressant action of agomelatine (S 20098) in a transgenic mouse model. Prog. Neuro-psychopharmacol. Biol. Psychiatry 29 (2005) 908-916
8. Benca R.M., Obermeyer W.H., Thisted R.A., and Gillin J.C. Sleep and psychiatric disorders. A meta-analysis. Arch. Gen. Psychiatry 49 (1992) 651-668
9. Benedetti F., Serretti A., Colombo C., Barbini B., Lorenzi C., Campori E., and Smeraldi E. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am. J. Med. Genet. Part B (Neuropsychiatr. Genet.) 123 (2003) 23-26
10. Benedetti F., Bernasconi A., Lorenzi C., Pontiggia A., Serretti A., Colombo C., and Smeraldi E. A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci. Lett. 355 (2004) 37-40
11. Benedetti F., Serretti A., Pontiggia A., Bernasconi A., Lorenzi C., Colombo C., and Smeraldi E. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta-50 T/C SNP. Neurosci. Lett. 376 (2005) 51-55
12. Borbély A.A. A two process model of sleep regulation. Hum. Neurobiol. 1 (1982) 195-204
13. Borbély A.A., and Wirz-Justice A. Sleep, sleep deprivation and depression. Hum. Neurobiol. 1 (1982) 205-210
14. Bourin M., Mocaër E., and Porsolt R. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J. Psychiatry Neurosci. 29 (2004) 126-133
15. Buijs R.M., and Kalsbeek A. Hypothalamic integration of central and peripheral clocks. Nat. Rev., Neurosci. 2 (2001) 521-526
16. Buysse D.J., Frank E., Lowe K.K., Cherry C.R., and Kupfer D.J. Electroencephalographic sleep correlates of episode and vulnerability to recurrence in depression. Biol. Psychiatry 41 (1997) 406-418
17. Carney C.E., Segal Z.V., Edinger J.D., and Krystal A.D. A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder. J. Clin. Psychiatry 68 (2007) 254-260
18. Cartwright R.D. Rapid eye movement sleep characteristics during and after mood-disturbing events. Arch. Gen. Psychiatry 40 (1983) 197-201
19. Carvalho L.A., Gorenstein C., Moreno R.A., and Markus R.P. Melatonin levels in drug-free patients with major depression from the southern hemisphere. Psychoneuroendocrinology 31 (2006) 761-768
20. Casper R.C., Redmond Jr. D.E., Katz M.M., Schaffer C.B., Davis J.M., and Koslow S.H. Somatic symptoms in primary affective disorder: presence and relationship to the classification of depression. Arch. Gen. Psychiatry 42 (1985) 1098-1104
21. Chang P.P., Ford D.E., Mead L.A., Cooper-Patrick L., and Klag M.J. Insomnia in young men and subsequent depression. The John Hopkins precursors study. Am. J. Epidemiol. 146 (1997) 105-114
22. Checkley S.A., Murphy D.G., Abbas M., Marks M., Winton F., Palazidou E., Murphy D.M., Franey C., and Arendt J. Melatonin rhythms in seasonal affective disorder. Br. J. Psychiatry 163 (1993) 332-337
23. Claustrat B., Chazot G., Brun J., Jordan D., and Sassolas G. A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol. Psychiatry 19 (1984) 1215-1228
24. Dahl K., Avery D.H., Lewy A.J., Savage M.V., Brengelmann G.L., Larsen L.H., Vitiello M.V., and Prinz P.N. Dim light melatonin onset and circadian temperature during a constant routine in hypersomnic winter depression. Acta Psychiatr. Scand. 88 (1993) 60-66
25. Dalton E.J., Rotondi D., Levitan R.D., Kennedy S.H., and Brown G.M. Use of slow-release melatonin in treatment-resistant depression. J. Psychiatry Neurosci. 25 (2000) 48-52
26. Danilenko K.V., Putilov A.A., Russkikh G.S., Duffy L.K., and Ebbesson S.O. Diurnal and seasonal variations of melatonin and serotonin in women with seasonal affective disorder. Arctic Med. Res. 53 (1994) 137-145
27. de Wries M.W., and Peeters F.P. Melatonin as a therapeutic agent in the treatment of sleep disturbances in depression. J. Nerv. Ment. Dis. 185 (1997) 201-202
28. DeBruyne J.P., Weaver D.R., and Reppert S.M. CLOCK and NPAS2 have overlapping roles in the suprachiasmatic circadian clock. Nat. Neurosci. 10 (2007) 543-545
29. Desan P.H., Oren D.A., Malison R., Price L.H., Rosenbaum J., Smoller J., Charney D.S., and Gelernter J. Genetic polymorphism at the CLOCK gene locus and major depression. Am. J. Med. Genet. Part B (Neuropsychiatr. Genet.) 96 (2000) 418-421
30. Dietzel M., Saletu B., Lesch O.M., Sieghart W., and Schjerve M. Light treatment in depressive illness: polysomnographic, psychometric and neuroendocrinological findings. Eur. Neurol. 25 suppl 2 (1986) 93-103
31. Dolberg O.T., Hirschmann S., and Grunhaus L. Melatonin fort he treatment of sleep disturbances in major depressive disorder. Am. J. Psychiatry 155 (1998) 1119-1121
32. Dombrovski A.Y., Mulsant B.H., Houck P.R., Mazumdar S., Lenze E.J., Andreescu C., Cyranowski J.M., and Reynolds III C.F. Residual symptoms and recurrence during maintenance treatment of late-life depression. J. Affect. Disord. 103 (2007) 77-82
33. Duncan Jr. W.C. Circadian rhythms and the pharmacology of affective illness. Pharmacol. Ther. 71 (1996) 253-312
34. Eaton W.W., Badawi M., and Melton B. Prodromes and precursors: epidemiological data for primary prevention of disorders with slow onset. Am. J. Psychiatry 152 (1995) 967-972
35. Ford D.J., and Kamerow D.B. Epidemiological study of sleep disturbances and psychiatric disorders. Am. J. Med. Assoc. 262 (1989) 1479-1484
36. Fuchs E., Schmelting B., and Mocaer E. Effects of the novel antidepressant agomelatine (S 20098) and fluoxetine in chronically stressed tree shrews, an animal model of depression. Eur. Neuropsychopharmacol. 16 Suppl. 4 (2006) S338
37. Giedke H., and Schwarzler F. Therapeutic use of sleep deprivation in depression. Sleep Med. Rev. 6 (2002) 361-377
38. Giles D.E., Jarrett R.B., Roffwarg H.P., and Rush A.J. Reduced rapid eye movement latency: a predictor of recurrence in depression. Neuropsychopharmacology 1 (1987) 33-39
39. Giles D.E., Etzel B.A., Reynolds III C.F., and Kupfer D.J. Stability of polysomnographic parameters in unipolar depression: a cross-sectional report. Biol. Psychiatry 25 (1989) 807-810
40. Gillette M.U., and Mitchell J.W. Signalling in the suprachiasmatic nucleus: selectively responsive and integrative. Cell Tissue Res. 309 (2002) 99-107
41. Glickman G., Byrne B., Pineda C., Hauck W.W., and Brainard G.C. Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (LEDs). Biol. Psychiatry 59 (2006) 502-507
42. Goetze U., and Tölle R. Circadian rhythm of free urinary cortisol, temperature and heart rate in endogenous depressives and under antidepressant therapy. Neuropsychobiology 18 (1987) 175-184
43. Golden R.N., Gaynes B.N., Ekstrom R.D., Hamer R.M., Jacobsen F.M., Suppes T., Wisner K.L., and Nemeroff C.B. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am. J. Psychiatry 162 (2005) 656-662
44. Gordijin M.C., Beersma D.G., Bouhuys A.L., Reinink E., and Van den Hofdakker R.H. A longitudinal study of diurnal mood variation in depression; characteristics and significance. J. Affect. Disord. 31 (1994) 261-273
45. Gruca P., Przegalinski E., Mrowiec S., Lason M., and Papp M. Evidence for antidepressant- and anxiolitic-like activities of melatonin and agomelatine in animal models. Eur. Neuropsychopharmacol. 14 (2004) S230
46. Hastings M.H. Central clocking. Trends Neurosci. 20 (1997) 459-464
47. Iitaka C., Miyazaki K., Akaike T., and Ishida N. A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J. Biol. Chem. 280 (2005) 29397-29402
48. Jakubcakova V., Oster H., Tamanini F., Cadenas C., Leitges M., van der Horst G.T., and Eichele G. Light entrainment of the mammalian circadian clock by a PRKCA-dependent posttranslational mechanism. Neuron 54 (2007) 831-843
49. Klein D.C., Moore R.Y., and Reppert S.M. Suprachiasmatic Nucleus: The Mind's Clock (1991), Oxford University Press, New York, NY
50. Knowles J.B., Cairns J., McLean A.W., Delva N., Prowse A., Waldron J., and Letemendia F.J. The sleep of remitted bipolar depressives: comparison with sex and age-matched controls. Can. J. Psychiatry 31 (1986) 295-298
51. Kohsaka A., and Bass J. A sense of time. How molecular clocks organize metabolism. Trends Endocrinol. Metab. 18 (2007) 4-11
52. Krauchi K., Cajochen C., Mori D., Graw P., and Wirz-Justice A. Early evening melatonin and S-280098 advance circadian phase and nocturnal regulation of core body temperature. Am. J. Physiol. 272 (1997) R1178-R1188
53. Kupfer D.J., and Foster F.G. Interval between onset of sleep and rapid-eye-movement sleep as an indicator of depression. Lancet 2 (1972) 684-686
54. Kupfer D.J., Frank E., McEachran A.B., and Grochocinski V.J. Delta sleep ratio: a biological correlate of early recurrence in unipolar affective disorder. Arch. Gen. Psychiatry 47 (1990) 1100-1105
55. Kupfer D.J. Pathophysiology and management of insomnia during depression. Ann. Clin. Psychiatry 11 (1999) 267-276
56. Laposky A.D., Shelton J., Bass J., Dugovic C., Perrino N., and Turek F.W. Altered sleep regulation in leptin deficient mouse. Am. J. Physiol., Regul. Integr. Comp. Physiol. 4 (2006) 894-903
57. Leibenluft E., Nooman B.M., and Wehr T.A. Diurnal variation: reliability of measurement and relationship to typical and atypical symptoms of depression. J. Affect. Disord. 26 (1992) 199-204
58. Lemoine P., Guilleminault C., and Alvarez E. Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine. J. Clin. Psychiatry 68 (2007) 1723-1732
59. LeSauter J., and Silver R. Lithium lengthens the period of circadian rhythms in lesioned hamsters bearing SCN grafts. Biol. Psychiatry 34 (1993) 75-83
60. Levitan R.D. The chronobiology and neurobiology of winter seasonal affective disorder. Dialogues Clin. Neurosci. 9 (2007) 315-324
61. Lewy A.J., and Sack R.L. Exogenous melatonin's phase-shifting effects on the endogenous melatonin profile in sighted humans: a brief review and critique of the literature. J. Biol. Rhythms 12 (1997) 588-594
62. Lewy A.J., Nurnberger Jr. J.I., Wehr T.A., Pack D., Becker L.E., Powell R.L., and Newsome D.A. Supersensitivity to light: possible trait marker for manic-depressive illness. Am. J. Psychiatry 142 (1985) 725-727
63. Lewy A.J., Lefler B.J., Emens J.F., and Bauer V.K. The circadian basis of winter depression. PNAS 103 (2006) 7414-7419
64. Lewy A.J., Rough J.N., Songer J.B., Mishra N., Yuhas K., and Emens J.S. The phase shift hypothesis for the circadian component of winter depression. Dialogues Clin. Neurosci. 9 (2007) 291-299
65. Linkowski C., Mendlewicz J., Leclercq R., and Van Cauter E. The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J. Clin. Endocrinol. Metab. 61 (1985) 429-438
66. Liu C., Weaver D.R., Jin X., Shearman L.P., Pieschl R.L., Gribkoff V.K., and Reppert S.M. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 19 (1997) 91-102
67. Loo H., Daléry J., Macher J.P., and Payen A. Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin-agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders. Encephale 29 (2003) 165-171
68. Magnusson A., and Stefansson J.G. Prevalence of seasonal affective disorder in Iceland. Arch. Gen. Psychiatry 50 (1993) 947-951
69. Mansour H.A., Wood J., Logue T., Chowdari K.V., Dayal M., Kupfer D.J., Monk T.H., Devlin B., and Nimgaonkar V.L. Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia. Genes Brain Behav. 5 (2006) 150-157
70. Martinet L., Guardiola-Lemaitre B., and Mocaer E. Entrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependent. Pharmacol. Biochem. Behav. 54 (1996) 713-718
71. Mendlewicz J., Linkowski P., Kerkhofs M., Desmedt D., Golstein J., Copinschi G., and Van Cauter E. Diurnal hypersecretion of growth hormone in depression. J. Clin. Endocrinol. Metab. 60 (1985) 505-512
72. Millan M.J., Gobert A., Lejeune F., Dekeyne A., Newman-Tancredi A., Pasteau V., Rivet J.M., and Cussac D. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J. Pharmacol. Exp. Ther. 306 (2003) 954-964
73. Moore R.Y., and Speh J.C. Serotonin innervation of the primate suprachiasmatic nucleus. Brain Res. 1010 (2004) 169-173
74. Morera A.L., and Abreu P. Seasonality of psychopathology and circannual melatonin rhythm. J. Pineal Res. 41 (2006) 279-283
75. Nievergelt C.M., Kripke D.F., Barrett T.B., Burg E., Remick R.A., Sadovnick A.D., McElroy S.L., Keck Jr. P.E., Schork N.J., and Kelsoe J.R. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder. Am. J. Med. Genet. Part B (Neuropsychiatr. Genet.) 141 (2006) 234-241
76. Nurnberger Jr. J.I., Berrettini W., Tamarkin L., Hamovit J., Norton J., and Gershon E. Supersensitivity to melatonin suppression by light in young people at high risk for affective disorder. A preliminary report. Neuropsychopharmacology 1 (1988) 217-223
77. Ogden C.A., Rich M.E., Schork N.J., Paulus M.P., Geyer M.A., Lohr J.B., Kuczenski R., and Niculescu A.B. Candidate genes, pathways and mechanisms for bipolar (manic-depressive) and related disorders: an expanded convergent functional genomics approach. Mol. Psychiatry 9 (2004) 1007-1029
78. Ohayon M.M., and Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J. Psychiatr. Res. 37 (2003) 9-15
79. Olié J.P., and Kasper S. Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int. J. Neuropsychopharmacol. 10 (2007) 661-673
80. Parry B.L., and Newton R.P. Chronobiological basis of female-specific mood disorders. Neuropsychopharmacology 25 Suppl. 5 (2001) S102-S108
81. Parry B.L., Mendelson W.B., Duncan W.C., Sack D.A., and Wehr T.A. Longitudinal sleep EEG, temperature, and activity measurements across the menstrual cycle in patients with premenstrual depression and in age-matched controls. Psychiatry Res. 30 (1989) 285-303
82. Partonen T., Treutlein J., Alpman A., Frank J., Johansson C., Depner M., Aron L., Rietschel M., Wellek S., Soronen P., Paunio T., Koch A., Chen P., Lathrop M., Adolfsson R., Persson M.L., Kasper S., Schalling M., Peltonen L., and Schumann G. Three circadian clock genes Per2, Arntl, and Npas2 contribute to winter depression. Ann. Med. 39 (2007) 229-238
83. Peeters F., Berkhof J., Delenspaul P., Rottenberg J., and Nicolson N.A. Diurnal mood variation in major depressive disorders. Emotion 6 (2006) 383-391
84. Pickard G.E., and Rea M.A. Serotonergic innervation of the hypothalamic suprachiasmatic nucleus and photic regulation of circadian rhythms. Biol. Cell 89 (1998) 513-523
85. Pittendrigh C.S. Temporal organization: reflections of a Darwinian clock-watcher. Annu. Rev. Physiol. 55 (1993) 16-54
86. Prickaerts J., Moechars D., Cryns K., Lenaerts I., van Craenendonck H., Goris I., Daneels G., Bouwknecht J.A., and Steckler T. Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J. Neurosci. 26 (2006) 9022-9029
87. Quera Salva M.A., Vanier B., Laredo J., Hartley S., Chapotot F., Moulin C., Lofaso F., and Guilleminault C. Major depressive disorder, sleep EEG and agomelatine: an open-label study. Int. J. Neuropsychopharmacol. 10 (2007) 691-696
88. Quiroz J.A., Gould T.D., and Manji H.K. Molecular effects of lithium. Mol. Interv. 4 (2004) 259-272
89. Racagni G., Riva M., and Popoli M. The interaction between the internal clock and antidepressant efficacy. Int. Clin. Psychopharmacol. Suppl. 2 (2007) S9-S14
90. Reppert S.M., and Weaver D.R. Molecular analysis of mammalian circadian rhythms. Annu. Rev. Physiol. 63 (2001) 647-676
91. Riemann D., Berger M., and Voderholzer U. Sleep and depression: results from psychobiological studies: an overwiewoverview. Biol. Psychol. 57 (2001) 67-103
92. Rosen L.N., Targum S.D., Terman M., Bryant M.J., Hoffman H., Kasper S.F., Hamovit J.R., Docherty J.P., Welch B., and Rosenthal N.E. Prevalence of seasonal affective disorder at four latitudes. Psychiatry Res. 31 (1990) 131-144
93. Rosenthal N.E., Sack D.A., Gillin J.C., Lewy A.J., Goodwin F.K., Davenport Y., Mueller P.S., Newsome D.A., and Wehr T.A. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch. Gen. Psychiatry 41 (1984) 72-80
94. Roybal K., Theobold D., Graham A., DiNeri J.A., Russo S.J., Krishnan V., Chakravarty S., Peevey J., Oehrlein N., Birnbaum S., Vitaterna M.H., Orsulak P., Takahashi J.S., Nestler E.J., Carlezon Jr. W.A., and McClung C.A. Mania-like behavior induced by disruption of CLOCK. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 6406-6411
95. Rush A.J., Erman M.K., Giles D.E., Schlesser M.A., Carpenter G., Vasavada N., and Roffwarg H.P. Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Arch. Gen. Psychiatry 43 (1986) 878-884
96. Sangoram A.M., Saez L., Antoch M.P., Gekakis N., Staknis D., Whiteley A., Fruechte E.M., Vitaterna M.H., Shimomura K., King D.P., Young M.W., Weitz C.J., and Takahashi J.S. Mammalian autoregulatory loop: a timeless ortholog and mPer1 interact and negatively regulate CLOCKBMAL1-induced transcription. Neuron 21 (1998) 1101-1113
97. Schwartz P.J., Rosenthal N.E., Turner E.H., Drake C.L., Liberty V., and Wehr T.A. Seasonal variation in core temperature regulation during sleep in patients with winter seasonal affective disorder. Biol. Psychiatry 42 (1997) 122-131
98. Serretti A., Benedetti F., Mandelli L., Lorenzi C., Pirovano A., Colombo C., and Smeraldi E. Genetic dissection of psychopathological symptoms: insomnia in mood disorders and CLOCK gene polymorphism. Am. J. Med. Genet. Part B (Neuropsychiatr. Genet.) 121 (2003) 35-38
99. Serretti A., Cusin C., Benedetti F., Mandelli L., Pirovano A., Zanardi R., Colombo C., and Smeraldi E. Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. Am. J. Med. Genet. Part B (Neuropsychiatr. Genet.) 137 (2005) 36-39
100. Simonneaux V., and Ribelayaga C. Generation of the melatonin endocrine message in mammals: a review of the complex regulation of melatonin synthesis by norepinephrine, peptides, and other pineal transmitters. Parmacol. Rev. 55 (2003) 325-395
101. Souétre E., Salvati E., Wehr T.A., Sack D.A., Krebs B., and Darcourt G. Twenty-four-hour profile of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects. Am. J. Psychiatry 145 (1988) 1133-1137
102. Sprouse J., Braseton J., and Reynolds L. Fluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firing. Biol. Psychiatry 60 (2006) 896-899
103. Srinivasan V., Smits M., Spence W., Lowe A.D., Kayumov L., Pandi-Perumal S.R., Parry B., and Cardinali D.P. Melatonin in mood disorders. World J. Biol. Psychiatry 7 (2006) 138-151
104. Steeves D.L., King D.P., Zhaio Y., Sangoram A.M., Du F., Bowcock A., Moore R., and Takahashi J. Molecular cloning and characterization of the human CLOCK gene: expression in the suprachiasmatic nucleus. Genomics 57 (1999) 189-200
105. Terman J.S., Terman M., Lo E.-S., and Cooper T.B. Circadian time of morning light administration and therapeutic response in winter depression. Arch. Gen. Psychiatry 58 (2001) 69-75
106. Thase M.E., Carpenter L., Kupfer D.J., and Frank E. Clinical significance of reversed vegetative subtypes of major depression. Psychopharmacol. Bull. 27 (1991) 17-22
107. Thase M.E., Fasiczka A.L., Berman S.R., Simons A.D., and Reynolds C.F. Electroencephalographic sleep profiles before and after cognitive behaviour therapy of depression. Arch. Gen. Psychiatry 55 (1998) 138-144
108. Turek F.W. From circadian rhythms to clock genes in depression. Int. Clin. Psychopharmacol. 22 Suppl. 2 (2007) S1-S8
109. Turek F.W., Joshu C., Kohsaka A., Lin E., Ivanova G., McDearmon E., Laposky A., Lasee-Olson S., Easton A., Jensen D.R., Eckel R.H., Takahashi J.S., and Bass J. Obesity and metabolic syndrome in circadian clock mutant mice. Science 308 (2005) 1043-1045
110. Uz T., Ahmed R., Akhisaroglu M., Kurtuncu M., Imbesi M., Dirim Arslan A., and Manev H. Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum. Neuroscience 134 (2005) 1309-1316
111. Van Cauter E., and Turek F.W. Depression: a disorder of timekeeping?. Perspect. Biol. Med. 29 (1986) 510-519
112. Van Cauter E., Leprouolt R., and Kupfer D.J. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J. Clin. Endocrinol. Metab. 81 (1996) 2468-2473
113. Van Reeth O., Olivares W., Turek F.W., Zhang Y., Zee P.C., Mocaer E., Defrance R., and Turek F.W. Comparative effects of a melatonin-agonist on the circadian system in mice and Syrian hamster. Brain Res. 762 (1997) 185-194
114. Wehr T.A., and Goodwin F.K. Circadian Rhythms in Psychiatry (1983), Pacific Grove, Boxwood, CA
115. Wehr T.A., Jacobsen F.M., Sack D.A., Arendt J., Tamarkin L., and Rosenthal N.E. Phototherapy of seasonal affective disorder. Time of day and suppression of melatonin are not critical for antidepressant effects. Arch. Gen. Psychiatry 43 (1986) 870-875
116. Wehr T.A., Duncan Jr. W.C., Sher L., Aeschbach D., Schwartz P.J., Turner E.H., Postolache T.T., and Rosenthal N.E. A circadian signal of change of season in patients with seasonal affective disorder. Arch. Gen. Psychiatry 58 (2001) 1108-1114
117. Welsh D.K., Logothetis D.E., Meister M., and Reppert S.M. Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms. Neuron 14 (1995) 697-706
118. Winkler D., and Kasper S. Seasonal affective disorder: from diagnosis to treatment. Medicographia 27 (2005) 247-253
119. Winkler D., Praschak-Rieder N., Willeit M., Lucht M.J., Hilger E., Konstantinidis A., Stastny J., Thierry N., Pjrek E., Neumeister A., Möller H.J., and Kasper S. Seasonal affective depression in 2 German speaking university centers: Bonn, Vienna. Clinical and demographic characteristics. Nervenarzt 73 (2002) 637-643
120. Wirz-Justice A. Biological rhythm disturbances in mood disorders. Int. Clin. Psychopharmacol. Suppl. 1 (2006) S11-S15
121. Wirz-Justice A., Graw P., Krauchi K., Gisin B., Jochum A., Arendt J., Fisch H.U., Buddeberg C., and Poldinger W. Light therapy in seasonal affective disorder is independent of time of day or circadian phase. Arch. Gen. Psychiatry 50 (1993) 929-937